These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 39085407)

  • 21. Nanovaccines with cell-derived components for cancer immunotherapy.
    Meng Z; Zhang Y; Zhou X; Ji J; Liu Z
    Adv Drug Deliv Rev; 2022 Mar; 182():114107. PubMed ID: 34995678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy.
    Wells K; Liu T; Zhu L; Yang L
    Nanoscale; 2024 Oct; 16(38):17699-17722. PubMed ID: 39257225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
    Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
    Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in cell membrane-based biomimetic nanodelivery systems for natural products.
    Zhang Y; Zhang Q; Li C; Zhou Z; Lei H; Liu M; Zhang D
    Drug Deliv; 2024 Dec; 31(1):2361169. PubMed ID: 38828914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
    Musetti S; Huang L
    ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-based nanosystems: the next generation of cancer immune therapy.
    Cheng Z; Fobian SF; Gurrieri E; Amin M; D'Agostino VG; Falahati M; Zalba S; Debets R; Garrido MJ; Saeed M; Seynhaeve ALB; Balcioglu HE; Ten Hagen TLM
    J Hematol Oncol; 2024 Jul; 17(1):53. PubMed ID: 39030582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.
    Gong P; Wang Y; Zhang P; Yang Z; Deng W; Sun Z; Yang M; Li X; Ma G; Deng G; Dong S; Cai L; Jiang W
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional nanoparticles for cancer immunotherapy.
    Saleh T; Shojaosadati SA
    Hum Vaccin Immunother; 2016 Jul; 12(7):1863-75. PubMed ID: 26901287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell membrane coated nanoparticles: next-generation therapeutics.
    Narain A; Asawa S; Chhabria V; Patil-Sen Y
    Nanomedicine (Lond); 2017 Nov; 12(21):2677-2692. PubMed ID: 28965474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Delivery for Cancer Immunotherapy and Vaccines.
    Batty CJ; Tiet P; Bachelder EM; Ainslie KM
    Pharm Nanotechnol; 2018; 6(4):232-244. PubMed ID: 30227827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Biomimetic Nanoparticles based on the Cell Membrane in Tumor Therapy.
    Gong Y; Huang J
    Curr Top Med Chem; 2023; 23(10):907-920. PubMed ID: 37102484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma.
    You H; Geng S; Li S; Imani M; Brambilla D; Sun T; Jiang C
    Biomaterials; 2024 Dec; 311():122694. PubMed ID: 38959533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetic cell-derived nanocarriers in cancer research.
    Soprano E; Polo E; Pelaz B; Del Pino P
    J Nanobiotechnology; 2022 Dec; 20(1):538. PubMed ID: 36544135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
    Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
    J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery.
    Hao W; Cui Y; Fan Y; Chen M; Yang G; Wang Y; Yang M; Li Z; Gong W; Yang Y; Gao C
    J Nanobiotechnology; 2021 Nov; 19(1):378. PubMed ID: 34801032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.